High frequency of disorders such as thalassemia, hemophilia A and sickle cell disease spurring effective screening approaches to ascertain appropriate prognosis
High frequency of disorders such as thalassemia, hemophilia A and sickle cell disease spurring effective screening approaches to ascertain appropriate prognosis
Fact.MR, Rockville MD: Award winning consulting firm Fact.MR’s ongoing hemoglobin testing systems market study forecasts an optimistic outlook for FY 2021-22, building upon previously accrued gains amidst surging blood testing volumes during the COVID-19 pandemic. Detecting possible presence of the SARS-CoV-2 amongst freshly infected patients as well as ascertaining antibody presence in formerly infected ones were primary growth drivers.
As the world gradually returns to normal, hemoglobin testing to determine possible genetic anomalies leading to the onset of key hematological disorders is resuming. According to the Centers for Disease Control and Prevention, Hemophilia A affects 1 in 5,000 male births across the US. In 66% of the cases, there is a family history of hemophilia. Likewise, according to W.H.O, around 1.1% of couples worldwide are at a risk of conceiving children with hemoglobin disorders.
Consequently, prominent healthcare providers are introducing highly advanced approaches to detect possible anomalies. A key component in the success of hemoglobin testing systems is the incorporation of technology. For instance, researchers at Purdue University have developed a mobile application which enables hemoglobin levels measurement without the need for blood extraction. The application comprises of a mobile version of spectroscopic analysis methods and clinical testing techniques, currently being deployed to assess oncology patients at the Indiana University Simon Research Center.
“A rapidly expanding population base is leading to an increase in prevalence of hematological disorders, predominantly across the developing world, prompting increased establishment of blood testing centers, stimulating demand for hemoglobin testing systems,” says the Fact.MR analyst.
For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=3985
Key Takeaways from Fact.MR’s Hemoglobin Testing Systems Study
- By product type, handheld hemoglobin testing devices to surge in popularity
- Clinicians are exhibiting greater inclination towards automatic hemoglobin testing devices
- By end-user, hospitals continue to dominate the global hemoglobin testing systems market
- US to remain a lucrative market for hemoglobin testing systems sales, attributed to high prevalence rate of hematological disorders
- Increased testing for myeloproliferative and lymphoproliferative disorders to heighten uptake in the UK
- Germany and France to register increased uptake amid treatment and diagnosis for sickle cell disease (SCD)
- India and China to emerge as lucrative markets, attributed to the presence of thalassemia positive patients
Hemoglobin Testing Systems Market- Prominent Drivers
- Surging incidences of multiple hematological disorders- benign and malignant- is enhancing hemoglobin testing systems sales
- Healthcare providers are expected to deploy mobile health tools to measure hemoglobin levels, paving way for new opportunities
- Growing numbers of blood banks and donation centers are directly bolstering hemoglobin testing systems demand
Hemoglobin Testing Systems Market- Key Restraints
- High sampling error margins encountered during blood testing to limit uptake of hemoglobin testing systems
- Heightened reagent kits procurement costs renders medium scale healthcare providers unable to procure advanced hemoglobin testing systems
Discover more about the hemoglobin testing system market with figures and data tables, along with the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/3985/hemoglobin-testing-systems-market
Competitive Landscape
Some of the key players operating in the global hemoglobin testing systems market are Mindray Medical International Limited, Sysmex Corporation, Beckman Coulter, Inc., Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Inc., Nihon Kohden Corporation, Siemens Healthineers and HemoCue India among others.
Beckman Coulter is a prominent face in the hemoglobin testing systems landscape, offering such equipment as the DxH 500, DxH 520, DxH 560, DxH 690T and DxH 900 Hematology Analyzers respectively. All the aforementioned product lines deploy automated repeat and reflex testing to reduce TAT to procure accurate results from difficult blood specimens.
Siemens Healthineers is another prominent player specializing in the hemoglobin testing systems domain. Since the past decade, the company offers the DCA Vantage® Analyzer, one of two HbA1c analyzers which are National Glycohemoglobin Standardization Program (NGSP) compliant.
More Insights on the Hemoglobin Testing Systems Market
The research study on the hemoglobin testing system treatment market by Fact.MR includes an in-depth analysis of major demand-driving factors and trends and a comprehensive evaluation of crucial aspects that are projected to carve the growth of the market. Market statistics have been elucidated based on product type (bench-top, handheld and others), operating type (automatic and semi-automatic) and end-users (hospitals, diagnostic laboratories and home) across seven major regions (North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle East & Africa).
Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=3985
Explore Fact.MR’s Coverage on the Healthcare Domain
Neonatal Ventilator Market: Fact.MR’s report highlights the growth trajectory on neonatal ventilator market for a period of ten years. According to the report, steady expansion has been projected for the neonatal ventilator market. This research study analyzes unveils the balance between supply and demand, that is expected to create growth opportunities for the neonatal ventilator market during the forecast period.
Vocal Biomarker Market: A comprehensive data analysis on the global vocal biomarker market is delivered in Fact.MR’s report, in order to help the clients in gaining a competitive edge and attracting potential customers. The report further aid in better understanding of the industry structure, and offers evaluations on the competition intensity attractiveness. Business strategists can leverage the intelligence offered in the report regarding latest opportunities and trends impacting the market expansion to make fact-based decisions for their businesses.
Sepsis Diagnosis Market: Sepsis is one of the leading causes of mortality around the globe. However, early detection can improve the outcomes, hence the demand for sepsis diagnostics is rising. The scope of Fact.MR’s report is to analyze the global sepsis diagnostics market for the upcoming forecast period, and provides readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global sepsis diagnostics market can benefit from the analysis offered in this report.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Market Intelligence Services: Marketngage.com
Source: Fact.MR